Hyperkalemia induced by the calcium channel blocker, benidipine

被引：10
|
作者：
Imamura, T [1 ]
Matsuura, Y [1 ]
Nagoshi, T [1 ]
Ishikawa, T [1 ]
Date, H [1 ]
Kita, T [1 ]
Matsuyama, A [1 ]
Matsuo, T [1 ]
Eto, T [1 ]
机构：
[1] Miyazaki Med Coll, Dept Internal Med 1, Miyazaki 8891692, Japan
来源：
INTERNAL MEDICINE | 2003年 / 42卷 / 06期
关键词：
hyperkalemia; benidipine; calcium channel blocker; potassium; side effect;
D O I：
10.2169/internalmedicine.42.503
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 73-year-old hypertensive, non-diabetic woman without obvious renal dysfunction had frequently been hyperkalemic over four years after receiving antihypertensive drugs including the calcium channel blocker (CCB) benidipine. One week after all medications were accidentally discontinued, the serum potassium level returned to normal. After we obtained the informed consent of the patient, benidipine alone was administered again for over two weeks and hyperkalemia developed once more. This previously uncommon side effect of hyperkalemia induced by benidipine is not very serious but it is apt to be overlooked. Since CCBs are now widely prescribed, the development of hyperkalemia should be considered.
引用
收藏
页码：503 / 506
页数：4
相关论文
共 50 条
  • [21] Calcium channel blocker-induced gingival enlargement
    R Livada
    J Shiloah
    Journal of Human Hypertension, 2014, 28 : 10 - 14
  • [22] Calcium channel blocker-induced gingival enlargement
    Livada, R.
    Shiloah, J.
    JOURNAL OF HUMAN HYPERTENSION, 2014, 28 (01) : 10 - 14
  • [23] Calcium Channel Blocker-induced Gingival Overgrowth
    Matsuura, Hiroki
    Fujiwara, Takashi
    Miyashita, Shiori
    INTERNAL MEDICINE, 2019, 58 (01) : 157 - 157
  • [24] How a dihydropyridine calcium channel blocker, benidipine, acts on ambulatory blood pressure influenced by daily phisical activity
    A Nomura
    S Kakinoki
    S Takechi
    A Kitabatake
    Journal of Human Hypertension, 1997, 11 : 823 - 823
  • [25] Renoprotective effect and cost-effectiveness of using benidipine, a calcium channel blocker, to lower the dose of angiotensin receptor blocker in hypertensive patients with albumiuria
    Saito, Fumio
    Fujita, Hirotaka
    Takahashi, Atsuhiko
    Ichiyama, Izumi
    Harasawa, Shinsuke
    Oiwa, Kouji
    Takahashi, Naoyuki
    Otsuka, Yuji
    Uchiyama, Takashi
    Kanmatsuse, Katsuo
    Kushiro, Toshio
    HYPERTENSION RESEARCH, 2007, 30 (01) : 39 - 47
  • [26] Benidipine:: A new Ca2+ channel blocker with a cardioprotective effect
    Kitakaze, M
    Karasawa, A
    Kobayashi, H
    Tanaka, H
    Kuzuya, T
    Hori, M
    CARDIOVASCULAR DRUG REVIEWS, 1999, 17 (01): : 1 - 15
  • [27] Renoprotective Effect and Cost-Effectiveness of Using Benidipine, a Calcium Channel Blocker, to Lower the Dose of Angiotensin Receptor Blocker in Hypertensive Patients with Albumiuria
    Fumio Saito
    Hirotaka Fujita
    Atsuhiko Takahashi
    Izumi Ichiyama
    Shinsuke Harasawa
    Kouji Oiwa
    Naoyuki Takahashi
    Yuji Otsuka
    Takashi Uchiyama
    Katsuo Kanmatsuse
    Toshio Kushiro
    Hypertension Research, 2007, 30 : 39 - 47
  • [28] Comparison of the Effects of an L- and T-Type Calcium Channel Blocker (Benidipine) with an L-Type Dominant Calcium Channel Blocker (Amlodipine) on Hypertension and Albuminuria in Patients with Type 2 Diabetes
    Yamane, Yuko
    Yamaguchi, Toru
    Kanazawa, Ippei
    Murase, Akihiko
    Tsumori, Michihiro
    Yamane, Takeshi
    Sugimoto, Toshitsugu
    DIABETES, 2009, 58 : A212 - A212
  • [29] Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension
    Yasunari, Kenichi
    Maeda, Kensaku
    Nakamura, Munehiro
    Watanabe, Takanori
    Yoshikawa, Junichi
    HYPERTENSION RESEARCH, 2005, 28 (02) : 107 - 112
  • [30] A Potent 1,4-Dihydropyridine L-type Calcium Channel Blocker, Benidipine, Promotes Osteoblast Differentiation
    Y. Nishiya
    N. Kosaka
    M. Uchii
    S. Sugimoto
    Calcified Tissue International, 2002, 70 : 30 - 39
12345